The completed equity investment strengthens ties between MINDCURE and ATMA VANCOUVER, BC, March 2, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the “Company”), a leader in developing technology to advance psychedelic-related treatments, is pleased to announce the completion of its initial strategic equity investment of equal to approximately 13%

Source

Previous articlePsychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful Completion of Reverse Take-Over Transaction
Next articleNuminus and Syreon Provide Psilocybin Compassionate Access Trial Update